These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2074657)

  • 1. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism.
    Don BR; Schambelan M
    Kidney Int; 1990 Dec; 38(6):1159-63. PubMed ID: 2074657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient hyporeninemic hypoaldosteronism in acute glomerulonephritis.
    Watanabe T; Nitta K
    Pediatr Nephrol; 2002 Nov; 17(11):959-63. PubMed ID: 12432442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitor-related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature.
    Unsal Y; Baltu D; Gulhan B; Okur FV; Ozaltın F; Düzova A; Topaloğlu R; Ozon ZA; Gonç EN
    Pediatr Transplant; 2024 Jun; 28(4):e14778. PubMed ID: 38767038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporeninemic hypoaldosteronism in two patients with systemic lupus erythematosus.
    Kiley J; Zager P
    Am J Kidney Dis; 1984 Jul; 4(1):39-43. PubMed ID: 6377883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyporeninemic hypoaldosteronism associated with focal glomerular sclerosis in a patient with chronic lymphocytic leukemia.
    Stalnikowicz R; Shalev O; Rosenmann E; Ben-Ishay D
    Nephron; 1982; 31(3):277-8. PubMed ID: 6750425
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating renin and aldosterone levels in children with organic acidemia-therapeutic experience with fludrocortisone.
    Tarçın G; Ahmadzada S; Saygılı S; Kaya A; Aktuğlu Zeybek AÇ; Ercan O
    Eur J Pediatr; 2023 Dec; 182(12):5447-5453. PubMed ID: 37773296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
    Pelleya R; Oster JR; Perez GO
    Am J Nephrol; 1983; 3(4):223-7. PubMed ID: 6351617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
    Kee CS; Choi JW; Chang DK; Ahn YH; Kim HJ
    J Korean Med Sci; 1993 Dec; 8(6):464-70. PubMed ID: 8179835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.
    Tan SY; Burton M
    Arch Intern Med; 1981 Jan; 141(1):30-3. PubMed ID: 7004370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyporeninemic hypoaldosteronism in sickle cell disease.
    Yoshino M; Amerian R; Brautbar N
    Nephron; 1982; 31(3):242-4. PubMed ID: 6750423
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)].
    Cuervas-Mons V; Moya Mir MS; Martín Martín F; Barbadillo García de Velasco R; Sánchez Miró I; Martín Jiménez T; Lorenz Pérez P
    Med Clin (Barc); 1980 Nov; 75(8):342-5. PubMed ID: 7003270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient hyperkalemia and hypoaldosteronism in a patient with acute glomerulonephritis.
    Opastirakul S; Chartapisak W
    J Med Assoc Thai; 2002 Apr; 85(4):509-13. PubMed ID: 12118500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.
    Tan SY; Shapiro R; Franco R; Stockard H; Mulrow PJ
    Ann Intern Med; 1979 May; 90(5):783-5. PubMed ID: 434681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible hyporeninemic hypoaldosteronism in a patient with tetraplegia.
    Inaba M; Katayama S; Omoto A; Maruno Y; Itabashi A; Ishii J; Morimoto S
    Endocrinol Jpn; 1989 Feb; 36(1):1-7. PubMed ID: 2543544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of lupus nephritis with hyporeninemic hypoaldosteronism].
    Wada J; Makino H; Ota Z; Yokoi T; Nagayama K; Asano K; Fukushima M
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):817-24. PubMed ID: 1770640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.
    Hahn JA; Zipser RD; Barg A; Stone RA; Zia PK; Hsueh WA; Horton R
    Prostaglandins Med; 1981 Jun; 6(6):549-56. PubMed ID: 6267637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular acidosis type IV as a complication of lupus nephritis.
    Sánchez-Marcos C; Hoffman V; Prieto-González S; Hernández-Rodríguez J; Espinosa G
    Lupus; 2016 Mar; 25(3):307-9. PubMed ID: 26345674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism.
    Sebastian A; Schambelan M; Lindenfeld S; Morris RC
    N Engl J Med; 1977 Sep; 297(11):576-83. PubMed ID: 18672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis.
    Sebastian A; Schambelan M; Sutton JM
    Am J Nephrol; 1984; 4(5):287-300. PubMed ID: 6524600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.